Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
1.16
-0.01 (-0.85%)
At close: Jun 05, 2025, 3:59 PM
1.00
-13.79%
Pre-market: Jun 06, 2025, 05:05 AM EDT

Sonnet BioTherapeutics Revenue

Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending March 31, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
$18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
$1.43K
Employees
13
Market Cap
3.67M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.